Addressing Sleep Onset and Maintenance Issues: Alternatives to Conventional Therapy – QI&CPD – Category 2

On completion of this program, participants will be better able to:

1. Distinguish between the modes of action of benzodiazepines, benzodiazepine receptor agonists and more novel therapies to address sleep onset and maintenance
2. Describe the role of novel therapies in the management of chronic insomnia
3. Identify patients with insomnia who would be appropriate for switching to novel therapies
4. Counsel patients regarding the potential risks associated with long term use of benzodiazepines and benzodiazepine receptor agonists(‘Z-drugs’), and how to switch from these drugs to novel therapies